
KP Tissue Inc. sees a notable uptick in its stock price, reflecting investor confidence.
KP Tissue Inc. (KPT.TO) has had a positive trading day, with its stock price climbing by 1.94% to close at CA$13.14. This increase comes amidst a stable market environment and shows the company's ongoing commitment to shareholder value.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
Market cap
$129.36M
P/E
14.3x
Div. yield
5.56%
Div. / share
$0.72
52W high
$13.61
52W low
$8.68
1W change
-0.93%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.6% Upside
Current Price
C$12.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
15.6%
Annualized
90-Day Vol
16.1%
Annualized
Trend (90d)
+48.6%
Annualized drift
90d Mean
C$15.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.56 | C$12.85 – C$14.31 |
| 60 trading days | C$14.37 | C$13.32 – C$15.51 |
| 90 trading days | C$15.23 | C$13.87 – C$16.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap of CA$129.26 million and a modest dividend yield of 5.54%, KP Tissue Inc. continues to be an attractive option for investors looking for stability and income.
KP Tissue Inc. Gains 1.94% in One Day
The stock's increase reflects a growing interest in KP Tissue, with its P/E ratio standing at 14.32, suggesting it may be undervalued compared to its peers.
Bull case
The recent rise in KP Tissue's stock price is due to its solid financial performance and consistent dividend payouts, which attract income-focused investors.
Bear case
Despite today's gains, KP Tissue's profit margin remains at 0%, indicating potential challenges in profitability that investors should watch closely.
Market Performance Overview
Advertisement
KP Tissue Inc. has recorded a significant gain of 1.94% in its stock price today, closing at CA$13.14. This performance comes as the company continues to focus on shareholder value through consistent dividend payments and effective management strategies.
Investor Sentiment and Future Outlook
The positive movement in KP Tissue's stock reflects a growing investor sentiment, particularly among those seeking stable returns. With a dividend yield of 5.54%, the company remains a viable option for income-seeking investors. However, the lack of profitability raises questions about long-term growth potential.
Understanding KP Tissue's Financial Metrics
KP Tissue's P/E ratio of 14.32 indicates that the stock may be undervalued compared to its industry peers. As the company navigates market challenges, investors should keep an eye on its financial health and operational performance. For more insights, check out the latest updates on KP Tissue Inc..
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


